August 14, 2026 - VivoSim Labs, Inc. (NASDAQ: VIVS) is emerging at the intersection of artificial intelligence, biotechnology, drug development, 3D human tissue models and New Approach Methodologies (NAMs) as pharmaceutical companies face increasing pressure to identify costly drug toxicity problems earlier in the development process.